User profiles for Jesper Eugen-Olsen
 | Jesper Eugen-OlsenCSO, ViroGates, Denmark Verified email at virogates.com Cited by 13324 |
[HTML][HTML] Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 …
Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …
suPAR: the molecular crystal ball
M Thunø, B Macho, J Eugen-Olsen - Disease markers, 2009 - content.iospress.com
soluble urokinase Plasminogen Activator Receptor (suPAR) levels reflect inflammation and
elevated suPAR levels are found in several infectious diseases and cancer. suPAR exists in …
elevated suPAR levels are found in several infectious diseases and cancer. suPAR exists in …
[HTML][HTML] Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor …
…, G Kronborg, M Tvede, J Petersen, J Eugen-Olsen… - Critical care, 2007 - Springer
Introduction Accurate and timely diagnosis of community-acquired bacterial infections in
patients with systemic inflammation remains challenging both for clinician and laboratory. …
patients with systemic inflammation remains challenging both for clinician and laboratory. …
[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
…, M Kyprianou, P Pickkers, J Eugen-Olsen… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
Effects of CCR5-Δ 32, CCR2-64I, and SDF-1 3′A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data
…, RA Coutinho, J Eugen-Olsen… - Annals of internal …, 2001 - acpjournals.org
Background: Studies relating certain chemokine and chemokine receptor gene alleles with
the outcome of HIV-1 infection have yielded inconsistent results. Objective: To examine …
the outcome of HIV-1 infection have yielded inconsistent results. Objective: To examine …
[HTML][HTML] Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
As of April 1, 2020, 885,689 cases of infections by the novel coronavirus SARS-CoV-2 (COVID-19)
have been recorded worldwide; 44,217 of them have died (https://www. worldometers…
have been recorded worldwide; 44,217 of them have died (https://www. worldometers…
An open label trial of anakinra to prevent respiratory failure in COVID-19
…, M Kyprianou, JWM van der Meer, J Eugen-Olsen… - Elife, 2021 - elifesciences.org
Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
[HTML][HTML] Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation
…, JEV Petersen, J Eugen-Olsen - Frontiers in …, 2021 - frontiersin.org
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation
that plays a major role in immunosenescence and in development and progression of many …
that plays a major role in immunosenescence and in development and progression of many …
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia
J Helweg-Larsen, TL Benfield, J Eugen-Olsen… - The Lancet, 1999 - thelancet.com
Background Sulpha drugs are widely used for the treatment and long-term prophylaxis of
Pneumocysfis carinii pneumonia (PCP) in HIV-1-infected individuals. Sulpha resistance in …
Pneumocysfis carinii pneumonia (PCP) in HIV-1-infected individuals. Sulpha resistance in …
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection
…, AC Lepri, F Blasi, J Eugen-Olsen - Blood, The Journal …, 2000 - ashpublications.org
Human immunodeficiency virus-1 (HIV-1) infection has been shown to result in up-regulation
of the urokinase-type plasminogen activator receptor (uPAR/CD87) on leukocytes in vitro …
of the urokinase-type plasminogen activator receptor (uPAR/CD87) on leukocytes in vitro …